IRCT20181224042091N1招募中3 期
Comparison of the effect of letrozole and neoadjuvant cheotherapy with chemotherapy alone on clinical response in advanced hormonal breast cancer
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 48
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- Female
入选标准
- •female with invasive breast cancer with positive hormone receptor and negative HER2 proven in pathology
- •Clinical Phase IIA to IIIC (T1-4, N0-3, M0)
- •Age more than 18 years
- •Good performance ((ECOG: 0-1
- •No history of previous chemotherapy
- •It is a conscientious informed consent
排除标准
- •Pregnancy / Breastfeeding
- •Liver cirrhosis
- •History of thromboembolic events in the patient
- •History of osteoporotic fractures
- •Patient's lack of cooperation in correct implementation of the treatment process in accordance with the recommended guidelines
研究者
相似试验
暂停
2 期
Study of neoadjuvant Letrozole combined with standerd chemotherapy for postmenopausal women with Endocrine-responsive Breast Cancer(subject of stage2,3A)Postmenopausal, hormone-receptor positive and resectable primary breast cancerJPRN-UMIN000002447iigata Cancer Center Hospital80
尚未招募
不适用
Study of clinical effect of Fulvestrant + letrozole + ribociclib triple therapy compared to standard treatment for hormone receptor positive metastatic breast cancerNeoplasmsKCT0008051Koera University Guro Hospital202
已完成
3 期
Effects of letrozole in combination with clomiphene on infertilityIRCT20160815029374N6Mazandaran University of Medical Sciences194
招募中
2 期
etrozole for IUIIRCT20220412054511N1Shahid Beheshti University of Medical Sciences80
已完成
2 期
Evaluation of efficacy of letrozole as a neoadjuvant endocrine therapy in postmenopausal patients with hormone receptor-positive breast cancerBreast cancerJPRN-UMIN000003101Tohoku University Graduate School of Medicine30